Senores Pharmaceuticals Makes Waves—Secures Wockhardt’s Enalapril ANDA for U.S. Push

Unknown Apr 02, 2026 1,350 Views

Senores Pharmaceuticals Limited made news in its recent acquisition, marking an aggressive push in the U.S. cardiovascular generics market. Senores, in turn, acquired Wockhardt Limited's USFDA-approved Abbreviated New Drug Application (ANDA) for Enalapril Maleate Tablets (2.5 mg, 5 mg, 10 mg,...